The Business of Clinical Trials Is Booming. Private Equity H

Private equity firms have moved aggressively into the healthcare industry’s more hidden niches: They are pouring billions into the business of clinical drug trials.

Related Keywords

Louisiana , United States , United Kingdom , Texas , Boston , Massachusetts , California , Houston , Canada , Lake Charles , San Francisco , Americans , Scotland , American , Devora Torrence , Linda Moore Schipani , Michael Fenne , Aaron Kesselheim , Steven Deeks , Nathalie Sohier , Marcella Alsan , Lyndon Fullen , Danaka Williams , Goldman Sach , Johns Hopkins , Mark Blumling , Yashaswini Singh , Cecil Nick , Johns Hopkins University , University Of California , Harvard Kennedy School , Linkedin , Harvard Medical School , Pfizer , Astrazeneca , Clinical Research Associates , Headlands Research , Johnson , South Texas , Provident Healthcare , Centex Studies , Pamplona Capital Management , California San Francisco , Private Equity Stakeholder Project ,